Search

GLP-1’s for Everything! The gift that keeps on giving… A review of the body of evidence and implications for managed care
Oncology Pipeline 2025: Emerging Breakthroughs and Trends
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into IgA Nephropathy and Duchenne Muscular Dystrophy
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into Sickle Cell Disease and Hemophilia
Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
Advancing Equitable Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Management Strategies in Managed Care
Charting a Better Path in Managing Multiple Myeloma: Overcoming Challenges and Driving Solutions
Mind Over Migraines: Disease Burden, Innovative Therapies, and Managed Care Trends in Treating Migraines
RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
Unlocking AI's Potential in Managed Care: An Actionable Roadmap
Beyond the Buzzwords: What We Learned Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance
From MFP to MFN — Price Controls, Politics & the Rebate Reckoning
Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
International Reference Pricing and Most-Favored-Nation Arrangements
Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

You are here